Incidence of Autoimmunity in Patients (pts) with Low-Risk (LR) Myelodysplastic Syndrome (MDS): 10 Years Follow-up

被引：2
|
作者：
Elkhanany, Ahmed [1 ]
Hanson, Curtis A. [1 ]
Patnaik, Mrinal [1 ]
Elliott, Michelle [1 ]
Litzow, Mark [1 ]
Al-Kali, Aref [1 ]
机构：
[1] Mayo Clin, Div Hematopathol, Rochester, MN USA
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.4931.4931
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4931
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Do low-risk patients really need follow-up after a pulmonary embolism?
    Alexander, Lesley
    Burnie, Susan
    Rossiter, Catherine
    Isles, Chris
    JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 2025,
  • [32] Incidence and risk factors of lymphedema after breast cancer treatment: 10 years of follow-up
    Padula Ribeiro Pereira, Ana Carolina
    Koifman, Rosalina Jorge
    Bergmann, Anke
    BREAST, 2017, 36 : 67 - 73
  • [33] Baseline predictors of response to treatment with darbepoetin-alpha (DA) in anemic patients with low-risk myelodysplastic syndrome (MDS)
    Gabrilove, J.
    Paquette, R.
    Lyons, R.
    Mushtaq, C.
    Sekeres, M.
    Tomita, D.
    Lillie, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [34] Low-risk MDS and immunosuppressive therapy: long-term follow-up and genetic outcome in 3 exceptional cases
    Schloegl, E.
    Shirneshan, K.
    Rittscher, K.
    Brzuszkiewicz, E. B.
    Ganster, C.
    Haase, D.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 135 - 135
  • [35] Romiplostim in Thrombocytopenic Patients (Pts) with Low-Risk or Intermediate-1 (Int-1)-Risk Myelodysplastic Syndrome (MDS) Results in Reduced Bleeding without Impacting Leukemic Progression: Updated Follow-up Results from a Randomized, Double-Blind, Placebo (PBO)-Controlled Study
    Kantarjian, Hagop
    Mufti, Ghulam J.
    Fenaux, Pierre
    Sekeres, Mikkael A.
    Szer, Jeffrey
    Platzbecker, Uwe
    Kuendgen, Andrea
    Gaidano, Gianluca
    Wiktor-Jedrzejczak, Wieslaw
    Franklin, Janet
    Giagounidis, Aristoteles
    BLOOD, 2015, 126 (23)
  • [36] Outcome Of Patients (pts) With Low and Intermediate-1 Risk Myelodysplastic Syndrome (MDS) After Hypomethylating Agent (HMA) Failure
    Jabbour, Elias
    Garcia-Manero, Guillermo
    Xiao, Lianchun
    Najla, Al Ali
    Mishra, Asmita
    Padron, Eric
    Lancet, Jeffrey E.
    Bryan, Jeffery
    Prescott, Hillary
    Steensma, David P.
    Sekeres, Mikkael A.
    Roboz, Gail J.
    List, Alan
    Kantarjian, Hagop M.
    Komrokji, Rami S.
    BLOOD, 2013, 122 (21)
  • [37] Follow-up of patients with low cardiovascular risk
    Vaillant-Roussel, Helene
    Cadwallader, Jean-Sebastien
    EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE, 2013, 24 (107): : 142 - 142
  • [38] Shared follow-up care for women with low-risk endometrial cancer
    Nehill, Caroline
    Milch, Vivienne
    Hughes, Felicity
    Anderson, Katrina
    Chynoweth, Jennifer
    Zorbas, Helen
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 109 - 110
  • [39] Patient initiated follow-up (PIFU) in low-risk endometrial cancer
    Shahreen, S.
    Marouli, M.
    Graham, R.
    MacDonald, N.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2024, 131 : 52 - 52
  • [40] Factors affecting prenatal follow-up in low-risk term pregnancy
    Firatligil, Fahri Burcin
    Fidan, Ulas
    CUKUROVA MEDICAL JOURNAL, 2019, 44 : 317 - 322
12345